Moderna Inc (MRNA)
$122.39
0.11 (0.09%)
MRNA Stock Quote Delayed 30 Minutes
Any COVID-19 Vaccine Upside Already Is Built Into MRNA Stock
If you buy Moderna today, you're betting on the mRNA technology behind it, not its coronavirus vaccine.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
46.87B
PE Ratio
-7.82
EPS
-15.66
Volume (Avg. Vol.)
677,684
Day's Range
$120.22 - $123.50
52-Week Range
$62.55 - $170.47
Dividend & Yield
N/A (N/A)
MRNA Stock Predictions, Articles, and Moderna Inc News
Why Investors Shouldn’t Pull the Trigger on Moderna Stock Yet
Fears about coronavirus are likely to ease in the coming days and weeks, and there won;t be much news about Moderna's vaccines.
Firm Up Your Anti-Coronavirus Holdings with Moderna Stock
MRNA stock investors could enjoy powerful returns if this company makes progress in its quest to develop an effective coronavirus vaccine.
Biotech Stocks: Coronavirus Response Shows How Far We’ve Come …
Look for biotech stocks as a group to gain more than 20% this year … with the best, most innovative firms more than doubling.
Moderna Stock’s Winning Streak Seems Likely to End
Investors are looking at Moderna’s coronavirus vaccine in a bubble. They’re assuming because Moderna reached the mile pole first, its vaccine is the one that will be most widely used.
Moderna Is a Great Company, But Don’t Buy Its Shares Until the Coronavirus Hype Fades
Moderna has a bright future. Unfortunately, hype surrounding a potential coronavirus vaccine makes MRNA stock risky here and now.
Moderna Will Rebound, But Wait for a Dip Lower to Buy Shares
A secondary offering put downward pressure on Moderna stock that will soon ease up. But wait for a dip toward $15 to buy shares.
Moderna Stock Ushers In the Next Wave of Biotech
Moderna may fail, but it's part of a new wave in biotech, where DNA becomes a programming language and anything becomes possible.
Moderna Therapeutics IPO: 7 Things for Potential Investors to Know
The Moderna Therapeutics IPO was launched on Friday, with the company being valued at $7.5 billion. The stock has already dropped in value.
